Summary Company Announcement Date: November 17, 2026 FDA Publish Date: November 17, 2026 Product Type: Food & Beverages Foodborne Illness Reason for Announcement: Recall Reason Description Potential to be contaminated with Salmonella Company Name: Larbi Inc. Brand Name: Brand Name(s) Herb to Body Product Description: Product Description Yellow Dock Root C/S Company Announcement Larbi Inc….
ALDI Recalls Priano Protein Carbonara Tortelloni and Priano Protein Herb & Cheese Tortelloni Because Of Possible Health Risk
Summary Company Announcement Date: November 16, 2026 FDA Publish Date: November 17, 2026 Product Type: Food & Beverages Foodborne Illness Reason for Announcement: Recall Reason Description Potential to be contaminated with Clostridium botulinum Company Name: ALDI Brand Name: Brand Name(s) Product Description: Product Description Protein Carbonara Tortelloni and Protein Herb & Cheese Tortelloni Company Announcement…
Naia, Inc. Recalls Chocolate Banana Bar Sorbetto Because of Undeclared Milk, Eggs, and Nuts
Summary Company Announcement Date: November 16, 2026 FDA Publish Date: November 17, 2026 Product Type: Food & Beverages Allergens Reason for Announcement: Recall Reason Description Undeclared Allergen – milk, eggs, tree nut (pistachio) Company Name: Naia, Inc. Brand Name: Brand Name(s) Product Description: Product Description Chocolate Banana Bar Sorbetto Company Announcement Naia, Inc. of Hercules,…
Convenience Kit Correction: Cardinal Health Issues Correction for Presource Packs Containing BD Alaris Pump Infusion Sets
This is an update to an Early Alert. The affected products and recommendations for what to do with the devices below have not changed. This recall involves correcting all devices, and does not involve removing them from where they are used or sold. The FDA has identified this recall as the most serious type. This…
MedWatch Alert: FDA Investigating Serious Risk of Malignancy Linked to Zolgensma Gene Therapy
November 6, 2026 TOPIC: FDA Investigating Serious Risk of Malignancy Linked to Zolgensma Gene Therapy: FDA Safety Communication AUDIENCE: Patient, Health Care Professional, Medical Genetics, Pediatric, Neurology, Nephrology ISSUE: The FDA has received postmarketing adverse event reports of malignancies in patients treated with Zolgensma, an adeno-associated virus (AAV) vector-based gene therapy, for spinal muscular atrophy…
Heart Pump Controller Recall: Abiomed Removes Automated Impella Controllers (AIC)
This is an update to an Early Alert. The affected products and recommendations for what to do with the devices below have not changed. This recall involves removing certain devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death…
Convenience Kit Correction: Cardinal Health Updates Use Instructions for Presource Packs Containing BD Alaris Pump Infusion Sets
This is an update to an Early Alert. The affected products and recommendations for what to do with the devices below have not changed. This recall involves updating instructions for using certain devices, and does not involve removing them from where they are used or sold. The FDA has identified this recall as the most…
Medline Updates Customers and Patients on Repair and Replace Program for Recall of Medline Brand Beds, Rails, Mattresses and Accessories
Summary Company Announcement Date: November 13, 2026 FDA Publish Date: November 13, 2026 Product Type: Medical Devices Reason for Announcement: Recall Reason Description Potential Fire Hazard and Entrapment Risk Company Name: Medline Brand Name: Brand Name(s) Product Description: Product Description Beds, Rails, Mattresses, and accessories Company Announcement Medline shares new customer communication, provides instructions for…
MedWatch Alert: FDA Requires Safety Labeling Changes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Due to Potential Increased Risk of Rare But Serious Eye Condition: FDA Safety Communication
AUDIENCE: Consumer, Patient, Health Care Professional, Pharmacy, Ophthalmology ISSUE: The FDA is informing patients and health care providers of a potential increased risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with use of glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications. NAION is a rare condition that can result in acute, painless, decreased vision in…
Game Changer Products LLC Issues Voluntary Nationwide Recall of 10 Day Forecast Capsules Due to the Presence of Undeclared Sildenafil and Acetaminophen
Summary Company Announcement Date: November 12, 2026 FDA Publish Date: November 12, 2026 Product Type: Dietary SupplementsDrugs Reason for Announcement: Recall Reason Description Tainted with Sildenafil and Acetaminophen Company Name: Game Changer Products, LLC Brand Name: Brand Name(s) 10 Day Forecast Product Description: Product Description 10 Day Forecast Capsules 3200mg Company Announcement FOR IMMEDIATE RELEASE…